Mostrar el registro sencillo del ítem
dc.contributor.author | Bernabé Ortiz, Antonio | |
dc.contributor.author | Sal Y Rosas, Víctor G. | |
dc.contributor.author | Ponce-Lucero, Vilarmina | |
dc.contributor.author | Cárdenas García-Santillán, María Kathia | |
dc.contributor.author | Carrillo Larco, Rodrigo Martín | |
dc.contributor.author | Diez-Canseco Montero, Francisco | |
dc.contributor.author | Pesantes Villa, María Amalia | |
dc.contributor.author | Sacksteder, Katherine A. | |
dc.contributor.author | Gilman, Robert Hugh | |
dc.contributor.author | Miranda, J. Jaime | |
dc.date.accessioned | 2020-07-14T00:00:57Z | |
dc.date.available | 2020-07-14T00:00:57Z | |
dc.date.issued | 2020 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12866/8234 | |
dc.description.abstract | Replacement of regular salt with potassium-enriched substitutes reduces blood pressure in controlled situations, mainly among people with hypertension. We report on a population-wide implementation of this strategy in a stepped-wedge cluster randomized trial (NCT01960972). The regular salt in enrolled households was retrieved and replaced, free of charge, with a combination of 75% NaCl and 25% KCl. A total of 2,376 participants were enrolled in 6 villages in Tumbes, Peru. The fully adjusted intention-to-treat analysis showed an average reduction of 1.29 mm Hg (95% confidence interval (95% CI) (-2.17, -0.41)) in systolic and 0.76 mm Hg (95% CI (-1.39, -0.13)) in diastolic blood pressure. Among participants without hypertension at baseline, in the time- and cluster-adjusted model, the use of the salt substitute was associated with a 51% (95% CI (29%, 66%)) reduced risk of developing hypertension compared with the control group. In 24-h urine samples, there was no evidence of differences in sodium levels (mean difference 0.01; 95% CI (0.25, -0.23)), but potassium levels were higher at the end of the study than at baseline (mean difference 0.63; 95% CI (0.78, 0.47)). Our results support a case for implementing a pragmatic, population-wide, salt-substitution strategy for reducing blood pressure and hypertension incidence. | en_US |
dc.language.iso | eng | |
dc.publisher | Springer Nature | |
dc.relation.ispartofseries | Nature Medicine | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es | |
dc.subject | Adult | en_US |
dc.subject | Female | en_US |
dc.subject | Humans | en_US |
dc.subject | Male | en_US |
dc.subject | Peru/epidemiology | en_US |
dc.subject | Surveys and Questionnaires | en_US |
dc.subject | Follow-Up Studies | en_US |
dc.subject | Residence Characteristics | en_US |
dc.subject | Blood Pressure/drug effects | en_US |
dc.subject | Case-Control Studies | en_US |
dc.subject | Diastole | en_US |
dc.subject | Hypertension/epidemiology/physiopathology/urine | en_US |
dc.subject | Incidence | en_US |
dc.subject | Potassium/urine | en_US |
dc.subject | Sodium Chloride, Dietary/adverse effects | en_US |
dc.subject | Sodium/urine | en_US |
dc.subject | Systole | en_US |
dc.title | Effect of salt substitution on community-wide blood pressure and hypertension incidence | en_US |
dc.type | info:eu-repo/semantics/article | |
dc.identifier.doi | https://doi.org/10.1038/s41591-020-0754-2 | |
dc.subject.ocde | https://purl.org/pe-repo/ocde/ford#1.06.03 | |
dc.subject.ocde | https://purl.org/pe-repo/ocde/ford#3.00.00 | |
dc.relation.issn | 1546-170X |
Ficheros | Tamaño | Formato | Ver |
---|---|---|---|
No hay ficheros asociados a este ítem. |